• 1
    Lemon SM, Shapiro CN. The value of immunization against hepatitis A. Infect Agents Dis 1994; 3:3849.
  • 2
    Arora NK, Nanda SK, Gulati S, Ansari IH, Chawla MK, Gupta SD, Panda SK. Acute viral hepatitis types E, A, and B singly and in combination in acute liver failure in children in north India. J Med Virol 1996; 48:215221.
  • 3
    Bismuth H, Samuel D, Gugenheim J, Castaing D, Bernuau J, Rueff B, Benhamou JP. Emergency liver transplantation for fulminant hepatitis. Ann Intern Med 1987; 107:337341.
  • 4
    Chenard-Neu MP, Boudjema K, Bernuau J, Degott C, Belghiti J, Cherqui D, Costes V, et al. Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure—a multicenter European study. Hepatology 1996; 23:11191127.
  • 5
    Bismuth H, Azoulay D, Samuel D, Reynes M, Grimon G, Majno P, Castaing D. Auxiliary partial orthotopic liver transplantation for fulminant hepatitis. The Paul Brousse experience. Ann Surg 1996; 224:712724.
  • 6
    Robertson BH, Jansen RW, Khanna B, Totsuka A, Nainan OV, Siegl G, Widell A, et al. Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol 1992; 73:13651377.
  • 7
    Costa-Mattioli M, Monpoeho S, Schvoerer C, Besse B, Aleman MH, Billaudel S, Cristina J, et al. Genetic analysis of hepatitis A virus outbreak in France confirms the co-circulation of subgenotypes Ia, Ib and reveals a new genetic lineage. J Med Virol 2001; 65:233240.
  • 8
    Brechot C, Bernuau J, Thiers V, Dubois F, Goudeau A, Rueff B, Tiollais P, et al. Multiplication of hepatitis B virus in fulminant hepatitis B. Br Med J (Clin Res Ed) 1984; 288:270271.
  • 9
    Gauss-Muller V, Deinhardt F. Effect of hepatitis A virus infection on cell metabolism in vitro. Proc Soc Exp Biol Med 1984; 175:1015.
  • 10
    Fleischer B, Fleischer S, Maier K, Wiedmann KH, Sacher M, Thaler H, Vallbracht A. Clonal analysis of infiltrating T lymphocytes in liver tissue in viral hepatitis A. Immunology 1990; 69:1419.
  • 11
    Vallbracht A, Maier K, Stierhof YD, Wiedmann KH, Flehmig B, Fleischer B. Liver-derived cytotoxic T cells in hepatitis A virus infection. J Infect Dis 1989; 160:209217.
  • 12
    Ida S, Tachikawa N, Nakajima A, Daikoku M, Yano M, Kikuchi Y, Yasuoka A, et al. Influence of human immunodeficiency virus type 1 infection on acute hepatitis A virus infection. Clin Infect Dis 2002; 34:379385.
  • 13
    Yotsuyanagi H, Iino S, Koike K, Yasuda K, Hino K, Kurokawa K. Duration of viremia in human hepatitis A viral infection as determined by polymerase chain reaction. J Med Virol 1993; 40:3538.
  • 14
    Fujiwara K, Yokosuka O, Ehata T, Imazeki F, Saisho H, Miki M, Omata M. Frequent detection of hepatitis A viral RNA in serum during the early convalescent phase of acute hepatitis A. Hepatology 1997; 26:16341639.
  • 15
    Bower WA, Nainan OV, Han X, Margolis HS. Duration of viremia in hepatitis A virus infection. J Infect Dis 2000; 182:1217.
  • 16
    Anderson DA. Cytopathology, plaque assay, and heat inactivation of hepatitis A virus strain HM175. J Med Virol 1987; 22:3544.
  • 17
    Morace G, Pisani G, Beneduce F, Divizia M, Pana A. Mutations in the 3A genomic region of two cytopathic strains of hepatitis A virus isolated in Italy. Virus Res 1993; 28:187194.
  • 18
    Lemon SM, Murphy PC, Shields PA, Ping LH, Feinstone SM, Cromeans T, Jansen RW. Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection: evidence for genetic recombination. J Virol 1991; 65:20562065.
  • 19
    Zhang H, Chao SF, Ping LH, Grace K, Clarke B, Lemon SM. An infectious cDNA clone of a cytopathic hepatitis A virus: genomic regions associated with rapid replication and cytopathic effect. Virology 1995; 212:686697.
  • 20
    Brack K, Frings W, Dotzauer A,Vallbracht A. A cytopathogenic, apoptosis-inducing variant of hepatitis A virus. J Virol 1998; 72:33703376.
  • 21
    Mao JS, Dong DX, Zhang HY, Chen NL, Zhang XY, Huang HY, Xie RY, et al. Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans. J Infect Dis 1989; 159:621624.
  • 22
    Durst RY, Goldsmidt N, Namestnick J, Safadi R, Ilan Y. Familial cluster of fulminant hepatitis A infection. J Clin Gastroenterol 2001; 32:453454.
  • 23
    Fujiwara K, Yokosuka O, Ehata T, Imazeki F, Saisho H. PCR-SSCP analysis of 5′-nontranslated region of hepatitis A viral RNA: comparison with clinicopathological features of hepatitis A. Dig Dis Sci 2000; 45:24222427.
  • 24
    Fujiwara K, Yokosuka O, Fukai K, Imazeki F, Saisho H, Omata M. Analysis of full-length hepatitis A virus genome in sera from patients with fulminant and self-limited acute type A hepatitis. J Hepatol 2001; 35:112119.
  • 25
    Lednar WM, Lemon SM, Kirkpatrick JW, Redfield RR, Fields ML, Kelley PW. Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol 1985; 122:226233.
  • 26
    Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G, Ferraro T, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998; 338:286290.